Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
| MER Indicator |
MER description |
Target Fiscal Year |
Target |
| C2.1.D |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
550 |
| C2.4.D |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
550 |
| C2.4.D |
Number of HIV-positive patients who were screened for TB in HIV care or treatment setting |
2015 |
455 |
| C2.5.D |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
550 |
| C2.5.D |
Number of HIV-positive patients in HIV care who started TB treatment |
2015 |
30 |
| CARE_NEW |
Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
774 |
| HTS_TST |
By Test Result: Negative |
2015 |
8,100 |
| HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
9,000 |
| HTS_TST |
Sum of Test Result disaggregates |
2015 |
9,000 |
| HTS_TST_POS |
By Test Result: Positive |
2015 |
900 |
| PMTCT_ARV |
Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) |
2015 |
5 |
| PMTCT_ARV |
Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery |
2015 |
2 |
| QI_SITE |
Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months |
2015 |
9 |
| QI_SITE |
Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC |
2015 |
9 |
| SITE_SUPP |
By program area/support type: Care and Support Direct Service Delivery (DSD) |
2015 |
9 |
| SITE_SUPP |
By program area/support type: HTC Direct Service Delivery (DSD) |
2015 |
9 |
| SITE_SUPP |
By program area/support type: TB/HIV Direct Service Delivery (DSD) |
2015 |
9 |
| SITE_SUPP |
By program area/support type: Treatment Direct Service Delivery (DSD) |
2015 |
8 |
| SITE_SUPP |
Number of unique sites supported by PEPFAR |
2015 |
9 |
| TB_ART |
The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period |
2015 |
115 |
| TB_SCREEN |
The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period |
2015 |
220 |
| TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2015 |
170 |
| TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2015 |
150 |
| TX_SITE |
Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation |
2015 |
9 |
| TX_SITE |
Total number of PEPFAR-supported ART sites |
2015 |
9 |
